PerkinElmer is a $2.8 billion global company committed to innovating for a healthier world. We create the instruments, tests and software used by scientists, researchers, and clinicians to address the most critical challenges across science and healthcare. We strategically partner with customers to enable earlier, more accurate insights, supported by deep market knowledge and technical expertise. Our dedicated team of about 16,000 employees is passionate about helping them work to create healthier families, improve the quality of life and sustain the wellbeing of people worldwide.

Throughout comprehensive portfolio, we serve four market segments to help customers:

DIAGNOSTICS • Test expectant mothers for pregnancy-related health risks and fetal abnormalities. Screen new born babies for genetic mutations that areassociated with life-threatening disorders • Accelerate detection of rare diseases, autoimmune disorders,allergies and infectious diseases

LIFE SCIENCES • Advance innovations in cancer cells, infectious microorganisms and neurological pathways • Validate chemical compounds, molecular data and biomarker insights to uncover drug candidates • Develop more effective medicines and biotherapeutics, bringing treatments to market faster

FOOD • Maintain safety and quality of food/beverage products by detecting fraudulent ingredients or toxins •analyze cannabis and hempforun safe pesticide levels, harmful residues and product impurities • Boost crop yield and enhance plant/grain quality to maximize productivity in sub-optimal conditions.

APPLIED MARKETS Ensure the air we breathe and water we drink are free of dangerous pollutants and contaminants • Detect and quantify concentrations of lead, heavy metals and other toxic elements in soil and water • Optimize performance and assure the quality of industrial products (gas, biofuels lubricants, petrochemicals, polymers)